Virginia Retirement Systems ET AL purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 35,300 shares of the medical research company’s stock, valued at approximately $2,094,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of A. Trust Co. of Vermont boosted its position in Agilent Technologies by 8.1% in the first quarter. Trust Co. of Vermont now owns 2,743 shares of the medical research company’s stock valued at $145,000 after buying an additional 205 shares in the last quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC boosted its stake in shares of Agilent Technologies by 17.2% in the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock worth $196,000 after buying an additional 486 shares in the last quarter. Teacher Retirement System of Texas acquired a new stake in shares of Agilent Technologies during the second quarter worth about $200,000. ELM Advisors LLC acquired a new stake in shares of Agilent Technologies during the second quarter worth about $202,000. Finally, Penserra Capital Management LLC boosted its stake in shares of Agilent Technologies by 9.5% in the first quarter. Penserra Capital Management LLC now owns 3,496 shares of the medical research company’s stock worth $184,000 after buying an additional 304 shares in the last quarter.

Agilent Technologies, Inc. (NYSE A) opened at 63.49 on Wednesday. The company has a market cap of $20.44 billion, a P/E ratio of 32.74 and a beta of 1.30. The stock has a 50 day moving average of $60.73 and a 200-day moving average of $56.62. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $63.63.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. Equities research analysts expect that Agilent Technologies, Inc. will post $2.32 EPS for the current year.

TRADEMARK VIOLATION WARNING: “35,300 Shares in Agilent Technologies, Inc. (A) Acquired by Virginia Retirement Systems ET AL” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/08/30/35300-shares-in-agilent-technologies-inc-a-acquired-by-virginia-retirement-systems-et-al.html.

A has been the subject of a number of recent analyst reports. Robert W. Baird upped their price target on shares of Agilent Technologies from $57.00 to $62.00 and gave the company an “outperform” rating in a report on Wednesday, May 24th. Jefferies Group LLC reissued a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a research report on Wednesday, August 9th. Morgan Stanley increased their price target on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 24th. BidaskClub lowered shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Finally, Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price target for the company in a research report on Tuesday, May 16th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and a consensus price target of $63.18.

In related news, insider Patrick Kaltenbach sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $61.26, for a total transaction of $306,300.00. Following the completion of the transaction, the insider now directly owns 45,138 shares in the company, valued at approximately $2,765,153.88. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Didier Hirsch sold 5,710 shares of the business’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $60.60, for a total value of $346,026.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 122,308 shares of company stock valued at $7,578,624.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.